Skip to content
Search

Latest Stories

Johnson & Johnson baby shampoo fails quality tests in India

JOHNSON & JOHNSON'S (J&J) baby shampoo samples failed quality tests conducted by the northwestern Indian state of Rajasthan, according to a public notice from the state's drugs watchdog, findings that were rejected by the US drug maker.

This comes just a few months after Indian authorities launched an investigation into J&J's baby powder to see if it contains cancer-causing asbestos.


J&J said in late February it had resumed production of baby talc after government tests found no asbestos in the product.

The Rajasthan drugs control organisation's notice dated March 5 said that the samples of J&J's baby shampoo taken from two batches had failed the quality test as they contained "harmful ingredients". It did not elaborate.

A J&J spokeswoman said that the results it received from the watchdog indicated that formaldehyde had been discovered in the samples.

Formaldehyde, used in making building materials, is a known carcinogen.

"We do not accept the interim results given to us, which mentioned samples to 'contain harmful ingredients- identification positive for formaldehyde,'" she said.

"We unequivocally maintain that our products are safe and our assurance process is amongst the most rigorous in the world," the J&J spokeswoman said, adding that the company has contested the interim test results of the government analysis that were based on "unknown and unspecified methods".

The two batches of the baby shampoo tested are due to expire in September 2021 and were manufactured at the company's plant in the northern state of Himachal Pradesh, according to the watchdog's notice.

"We have confirmed to the Indian authorities that we do not add formaldehyde as an ingredient in our shampoo nor does Johnson's baby shampoo contain any ingredient that can release formaldehyde over time," the company spokeswoman said.

The federal regulator and its counterparts in Indian states launched an investigation into J&J's baby powder following a Reuters report in December that the firm knew for decades that cancer-causing asbestos could be found in the product.

J&J has described the Reuters article as "one-sided, false and inflammatory".

(Reuters)

More For You

modi-trump-getty
Trump shakes hands with Modi during a joint press conference at Hyderabad House in New Delhi on February 25, 2020. (Photo: Getty Images)

Key issues in India, US trade talks

TRADE talks between India and the US have hit a roadblock over disagreements on duties for auto components, steel and farm goods, Indian government sources said to Reuters, dashing hopes of reaching an interim deal ahead of president Donald Trump's July 9 deadline to impose reciprocal tariffs.

Here are the key issues at play:

Keep ReadingShow less
Anil Agarwal

Vedanta Resources, which is based in the UK and owned by Indian billionaire Anil Agarwal, has been working on reducing its debt. (Photo credit: Getty Images)

Getty Images

Anil Agarwal’s Vedanta Resources signs £438 million refinancing deal

VEDANTA LTD said on Thursday that its parent company, Vedanta Resources, has signed a loan facility agreement worth up to £438 million with international banks to refinance existing debt.

The refinancing move, where old loans are replaced by new ones, often at better terms like lower interest rates, has led ratings agencies such as S&P Global Ratings and Moody's to upgrade their outlook on the company this year.

Keep ReadingShow less
Trump-Getty

Trump said that while deals are being made with some countries, others may face tariffs.

Getty Images

Trump says major trade deal with India may be finalised soon

US PRESIDENT Donald Trump on Friday said a "very big" trade deal could be finalised with India, suggesting significant movement in the ongoing negotiations between the two countries.

“We are having some great deals. We have one coming up, maybe with India. Very big one. Where we're going to open up India," Trump said at the “Big Beautiful Bill” event at the White House.

Keep ReadingShow less
Asda suffers nearly £600m loss as debt and IT costs surge

Asda co-ownerMohsin Issa. (Photo: Asda)

Asda suffers nearly £600m loss as debt and IT costs surge

ASDA, one of Britain’s largest supermarkets, has reported a pre-tax loss of £599 million for 2024, swinging sharply from a £180 million profit the previous year.

The loss comes despite total sales rising by over £1 billion to £26.8bn, as the retailer faces mounting debt costs, falling sales, and spiralling spending on a major IT overhaul, the Telegraph reported.

Keep ReadingShow less
Mounjaro

Mounjaro, or tirzepatide, is part of a new class of weight-loss medications, with trials showing patients losing an average of 20 per cent of their body weight after 72 weeks.

Reuters

Lilly to sell Mounjaro pens in India as Wegovy enters market

ELI LILLY said on Thursday that it has received approval from India's drug regulator to launch pre-filled injector pens of its weight-loss drug, Mounjaro.

The move gives the company more options to compete with Novo Nordisk, which recently launched its weight-loss drug Wegovy in the country.

Keep ReadingShow less